Biotech
AzurRx BioPharma Activates Additional Clinical Trial Sites in Turkey for Phase 2 Combination Therapy Trial of MS1819 in Cystic Fibrosis
Two clinical trial sites activated in Turkey, with patient screening initiated Follows activation of six clinical sites in Hungary and dosing of first eight patients Topline data expected in Q2 2021 NEW YORK, Oct. 14, more...
Biotech
Oncocyte Announces New Prospective Data Demonstrating That Treatment Informed by DetermaRx(TM) Significantly Improves Lung Cancer Patient Survival
Data to be P resented by Dr . Gavi t t Woodard of Yale University at the IASLC 2020 North America Conference on Lung Cancer Results and Clinical Utility to be Discussed During KOL W more...
Health
VolitionRx Limited Announces Details for Virtual Capital Markets Day 2020
VolitionRx Limited Announces Details for Virtual Capital Markets Day 2020 PR Newswire AUSTIN, Texas, Oct. 14, 2020 AUSTIN, Texas , Oct. 14, 2020 /PRNewswire/ — VolitionRx Limited (NYSE AMERICAN: VNRX) (“Volition”) a multi-national epigenetics company more...
Biotech
Aquestive Therapeutics to Announce Third Quarter Financial Results and Recent Business Highlights on November 4 and Host Conference Call on November 5 at 8:00 a.m. ET
WARREN, N.J., Oct. 14, 2020 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company focused on developing and commercializing differentiated products that address patients’ unmet needs and solve therapeutic problems, announced today that more...
Biotech
XOMA Earns $1.9 Million Associated with Two Partner Developments
Rezolute ’s recent private placement triggers $1.4 million payment to XOMA In an unrelated development, a partner initiated Phase 2 development of an undisclosed asset , which triggers $0.5 million milestone payment to XOMA EMERYVILLE, more...
Cannabis
BC Craft Supply Co. Introduces New BC Grown Cultivar From Vodis Pharmaceuticals Inc.
VANCOUVER, British Columbia, Oct. 14, 2020 (GLOBE NEWSWIRE) — BC Craft Supply Co. Ltd. (the “ Company ” or “ BC Craft ”) ( CSE:CRFT ) ( FSE:ZZD1 ) is pleased to announce a new more...
Health
BIOLASE Announces Preliminary Third Quarter Revenue Results; Reopening Of Dental Practices Drives Sequential Revenue Growth
BIOLASE Announces Preliminary Third Quarter Revenue Results; Reopening Of Dental Practices Drives Sequential Revenue Growth Virtual Investor and Analyst Event Being Held Today at 1:00 p.m. ET PR Newswire FOOTHILL RANCH, Calif., Oct. 14, 2020 more...
Biotech
Evelo Biosciences Completes Enrollment in Phase 1b Clinical Trial Cohort Evaluating EDP1815 in Atopic Dermatitis
–Data expected in 1Q 2021– CAMBRIDGE, Mass., Oct. 14, 2020 (GLOBE NEWSWIRE) — Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a new modality of orally delivered, systemically acting biologics, today announced that more...
Biotech
Actinium Pharmaceuticals, Inc. Expands R&D Capabilities with New Research Facility to Enhance Development of Next Generation Antibody Radiation Conjugates Leveraging Its Proprietary AWE Platform
Actinium Pharmaceuticals, Inc. Expands R&D Capabilities with New Research Facility to Enhance Development of Next Generation Antibody Radiation Conjugates Leveraging Its Proprietary AWE Platform Actinium Pharmaceuticals, Inc. Expands R&D Capabilities with New Research Facility to more...
Cannabis
Village Farms International’s CEO, Michael DeGiglio, to be Featured Speaker at Benzinga Cannabis Capital Virtual Conference Tomorrow, Thursday, October 15, 2020
Village Farms International’s CEO, Michael DeGiglio, to be Featured Speaker at Benzinga Cannabis Capital Virtual Conference Tomorrow, Thursday, October 15, 2020 PR Newswire VANCOUVER, BC, Oct. 14, 2020 VANCOUVER, BC , Oct. 14, 2020 /PRNewswire/ more...